›› 2019, Vol. 4 ›› Issue (8): 43-45.

Previous Articles     Next Articles

Clinical Analysis of Intracranial and Extracranial Artery Bypass and Temporal Muscle Attachment
in the Treatment of Moyamoya Syndrome

Wu Wenxue1, Shi Fengcai1, Li Qiangfeng1, Li Xingchang1, Li Baocheng2*   

  1. (1. Department of Neurosurgery, People's Hospital of Pu'er City, Pu'er, Yunnan 665000, China; 2. Department of Neurosurgery,
    Jingcheng Hospital, Ruili, Yunnan 678600, China)
  • Received:2018-10-18 Revised:2019-05-12 Online:2019-08-15 Published:2019-08-15

Abstract:

Objective: To explore the clinical effects and influencing factors of superficial temporal arterial-middle cerebral artery
bypass and cerebral temporal muscle attachment in the treatment of moyamoya syndrome. Methods: 22 patients with moyamoya
syndrome in People's Hospital of Pu'er City from 2014 to 2018 were selected. Meanwhile, imaging indications showed that all patients
had cerebral infarction lesions, and the symptoms were varying degrees of dizziness and limb decline. By DSA, the patients were
diagnosed with obvious moyamoya vessels, and underwent surgeries in 7 to 14 days. Among them, 9 cases had superficial temporal
artery-middle cerebral artery bypass and temporal muscle attachment, 13 cases were treated by temporal muscle attachment and dural
vascular inversion. Results: 6 months after the surgeries, all patients' ischemic symptoms improved obviously. Muscle strength and limb
movement were significantly improved in 15 cases. DSA demonstrated vascular hyperplasia was obvious in the lesion area in 18 patients,
and external carotid arteriography showed obvious external carotid artery blood supply in the lesion area. Conclusion: Superficial
temporal artery-middle cerebral artery bypass and temporal muscle attachment are safe and effective in the treatment of patients with
moyamoya syndrome and cerebral infarction.

Key words: moyamoya syndrome, superficial temporal artery-middle cerebral artery bypass, cerebral temporal muscle attachment, cerebral infarction

CLC Number: